• 1
    Syrjanen S. HPV infections and tonsillar carcinoma. J Clin Pathol 2004; 57: 44955.
  • 2
    Frisch M, Goodman MT. Human papillomavirus-associated carcinomas in Hawaii and the mainland. Cancer 2000; 88: 14649.
  • 3
    Munger K, Werness BA, Dyson N, Phelps WC, Harlow E, Howley PM. Complex formation of human papillomavirus E7 protrein with the retinoblastoma tumor suppressor gene product. EMBO J 1989; 8: 4099105.
  • 4
    Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 1990; 63: 112936.
  • 5
    Zur Hausen H. Papillomaviruses in human cancers. Proc Assoc Am Physicians 1999; 111: 5817.
  • 6
    Dong XP, Stubenrauch F, Beyer-Finkler E, Pfister H. Prevalence of deletion of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994; 58: 8038.
  • 7
    Swoboda A, Fabrizii V. Tonsillar carcinoma in a renal graft recipient treated with cyclosporine. Clin Nephrol 1993; 39: 2724.
  • 8
    Hemminki K, Dong C, Frish M. Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev 2000; 9: 4337.
  • 9
    Pintos J, Franco EL, Black MJ, Bergeron J, Arella M. Human papillomavirus and prognoses of patients with cancers of the upper aerodigestive tract. Cancer 1999; 85: 19039.
  • 10
    Cho NH, An HJ, Jeong JK, Kans S, Kim JW, Kim YT, Park TK. Genotyping of 22 human papillomavirus types by DNA chip in Korean women: comparison with cytologic diagnosis. Am J Obstet Gynecol 2003; 188: 5662.
  • 11
    Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002; 40: 88691.
  • 12
    Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B. Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 1998; 17: 14653.
  • 13
    Vernon SD, Unger ER, Miller DL, Lee DR, Reeves WC. Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 1997; 74: 506.
  • 14
    Alazawi W, Pett M, Arch B, Scott L, Freeman T. Changes in cervical keratinocyte gene expression associated with integration of human papillomavirus 161. Cancer Res 2002; 62: 695965.
  • 15
    Randolph B, Pai S, Wayne M, Maura L, Danish H. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res 2000; 6: 41715.
  • 16
    Baker CC, Phelps WC, Lindgren V, Braun MJ, Gonda MA, Howley PM. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J Virol 1987; 61: 96271.
  • 17
    el Awady MK, Kaplan JB, O'Brien SJ, Burk RD. Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 1987; 159: 38998.
  • 18
    Begum S, Cao D, Gillison M, Zahurak M, Westra WH. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005; 11: 56949.
  • 19
    Mellin H, Dahlgren L, Munik-Wikland E, Lindholm J, Rabbani H, Kalantari M, Dalianis T. Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer 2002; 102: 1528.
  • 20
    Venuti A, Manni V, Morello R, De Marco F, Marzetti F, Marcante ML. Viral integration into the host genome occurred in 43% of cases of HPV-16 and in 20% of cases of HPV-6. Viral RNA expression was detected by reverse transcription-PCR only in HPV-16 positive tumors. J Med Virol 2000; 60: 396402.
  • 21
    Koskinen WJ, Chen RW, Leivo I, Makitie A, Back L, Kontio R, Suuronen R, Lindqvist C, Auvinen E, Molijn A, Quint WG, Vaheri A, et al. Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer 2003; 107: 4016.
  • 22
    Si HX, Tsao SW, Poon CSP, Wong YC, Cheung ALM. Physical status of HPV-16 in esophageal squmaous cell carcinoma. J Clin Virol 2005; 32: 1923.
  • 23
    Badaracco G, Venuti A, Sedati A, Marcante ML. HPV-16 and HPV-18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 2002; 67: 57482.
  • 24
    Tonon SA, Picooni MA, Bos PD, Galuppo J, Aldonio LV, Teyssie AR. Physical status of the E2 human papillomavirus 16 viral gene in cervical preneopalstic and neopalstic lesions. J Clin Virol 2001; 21: 12934.
  • 25
    Aoyama C, Peters J, Senadheera S, Liu P, Shimada H. Uterine cervical dysplasia and cancer: identification of c-myc status by quantitative polymerase chain reaction. Diagn Mol Pathol 1998; 7: 32430.
  • 26
    Abba MC, Laguens RM, Dulout FN, Golijow CD. The c-myc activation in cervical carcinomas and HPV 16 infections. Mutat Res 2004; 557: 1518.
  • 27
    Sastre-Garau X, Favre M, Couturier J, Orth G. Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumors. J Gen Virol 2000; 81: 198393.
  • 28
    Pim D, Collins M, Banks L. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. Oncogene 1992; 7: 2732.
  • 29
    Zhang PL, Pellitteri PK, Law A, Gilroy PA, Wood GC, Kennedy TL, Blasick TM, Lun M, Schuerch C, Brown RE. Overexpression of phosphorylated nuclear factor-κ B in tonsillar squamous cell carcinoma and high-grade dysplasia is associated with poor prognosis. Mod Pathol 2005; 18: 92432.
  • 30
    Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enommoto N, Ooi A. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer 2006; 118: 117380.
  • 31
    Li Y, Nichols MA, Shay JW, Xiong Y. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 1994; 54: 607882.
  • 32
    Klussmann JP, Gultekin E, Weissenborn SJ, Wieland U, Dries V, Dienes HP, Eckel HE, Pfister HJ, Fuchs PG. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003; 162: 74753.
  • 33
    Mellin DH, Lindquist D, Bjornestal L, Ohlsson A, Dalianis T, Munk-Wikland E, Elmberger G. P16 (INK4a) correlates to human papillomavirus presence, response to radiotherapy and clinical outcome in tonsillar carcinoma. Anticancer Res 2005; 25: 437584.
  • 34
    Nakayama K, Hatakeyama S, Nakayama K. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27 Kip1. Biochem Biophys Res Commun 2001; 282: 85360.
  • 35
    Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, Murphy LM, Chen L, Wettstein PJ, Gostout B, Ferrone S, Strome SE. Characterization of antigen processing machinery and survivin expression in tonsillar squamous cell carcinoma. Cancer 2003; 97: 220311.
  • 36
    Korokawa T, Miyamoto M, Kato K, Cho Y, Kawarada Y, Hida Y, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H. Overexpresion of hypoxia-inducible factor 1a in esophageal squmaous cell carcinoma correlates with lymph node metastasis and pathologic stage. Br J Cancer 2003; 89: 10427.
  • 37
    Beasley NJP, Leek R, Alam M, Turley H, Cox GJ, Gatter K, Millard P, Fuggle S, Harris A. Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002; 62: 24937.